Healthcare can be complicated.
Your cardiology news shouldn’t be.
Join thousands of cardiology leaders today.
Cardiology Pharmaceuticals November 12, 2026
The First Ever Factor XIa Gets Approved for Secondary Stroke November 12, 2026
Adding anticoagulants to antiplatelet therapy after stroke has always meant trading clots for bleeds, but that’s changing thanks to Bayer’s asundexian (Sunharbo), which just became the first-ever FDA-approved Factor XIa inhibitor for secondary stroke prevention.
Structural Heart November 9, 2026
Can TAVR Make PROGRESS Against Moderate AS? November 9, 2026
To TAVR or not to TAVR, that is the question central to the PROGRESS trial presented at TCT 2026, and its results suggest the answer might be the former for certain high-risk patients with moderate AS.
Cardiac Imaging November 6, 2026
In My Practice: Using Cardiac CT to Keep Athletes in the Game November 6, 2026
Every week, my clinic sees very different kinds of hearts under the same word: "athlete."
Cardiology November 4, 2026
The Top Trends of TCT 2026 November 4, 2026
This year marked the 38th TCT 2026 conference, back on Cardiac Wire’s home turf in San Diego for only the second time. As the name implies catheter-based heart therapies are still the core of the meeting, but this year’s late-breakers and booth conversations showed just how much this cutting-edge cardiac segment is maturing.
